Tag: Combination Therapy

Finding the Magic Formula

By Cody R. Barnett, MRA Director of Communications | 7 February 2018 In Science, Treatment

Modern immunotherapy, with melanoma as its poster child, is changing the way we treat cancer - for good. But, so far at least, it isn't helping everyone. Many scientists believe that there isn't a single silver bullet to unleash the awesome power of our immune systems - and instead - that the future of oncology is finding just the right combination of therapies that push and pull from different directions to multiply and enhance each other's effectiveness.

Read More


Doubling Down: Brandon Barniea Bets Big on Combination Therapy

By Cody R. Barnett, MRA Director of Communications | 6 September 2017 In Melanoma Stories, Treatment

Brandon Barniea didn’t believe he needed to visit doctors. The athletic 35-year-old had always been healthy – even when his wife and two kids were sick at home with the flu, he would miraculously avoid falling ill. So, when he found what felt like “beads” in his neck, reality came crashing in; following a biopsy, he was diagnosed first with stage III melanoma in August 2015 and later that year it progressed to stage IV.

Read More


The Power of Combination Therapies: One Patient’s Road to Remission

By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 28 February 2017 In Science, Treatment

Metastatic melanoma can be a devastating diagnosis to receive. Just hearing the word cancer for most is terrifying. While the fear is understandable, today new targeted therapies and immunotherapies are delivering new hope for many.

Read More


Understanding Immunotherapy Part 3: CTLA-4

By Amrita Bhatt, MRA Intern | 15 June 2016 In Science, Treatment

Now that you’ve read our background on immunotherapy and learned about PD-1, it’s time to focus on another protein that plays a key role in cancer development, CTLA-4. What is CTLA-4? In addition to displaying PD-1 on the cell surface, T cells also display CTLA-4.

Read More


Ups and Downs for Melanoma. But Staying Focused.

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 25 June 2015 In Science

 This time a week ago I was jubilant. The SU2C-MRA Melanoma Dream Team’s paper describing a precision medicine approach to treating patients had just been published. And in the middle of the week an important article published in the prestigious scientific journal Cell describing the comprehensive genomic landscape of over...

Read More


The First FDA Approval of Two Melanoma Therapies in Combination

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 January 2014 In News

You may have heard this from other sources already, but we want to take a minute and explain why we’re so excited at MRA by some recent news. This week, GlaxoSmithKline announced that it had received approval from the U.S. Food and Drug Administration (FDA) of a combination treatment for melanoma.

Read More


Melanoma News Round-Up, November 22

22 November 2013 In News

There's been lots of exciting melanoma research in the news recently, especially since this week marked the 10th Annual Society For Melanoma Research (SMR) Congress meeting. Check out the stories below for all the research updates and stories you'll want to share with your friends and family! New Cancer Treatments...

Read More

Login

×